Bristol-Myers Squibb Co (LIM:BMY) Float Percentage Of Total Shares Outstanding: 99.97% (As of Jul. 07, 2026)


LIM:BMY Bristol-Myers Squibb Co LIM:BMY
57 GF Score
Price $56.98
GF Value $55.40
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Bristol-Myers Squibb Co Float Percentage Of Total Shares Outstanding?

Bristol-Myers Squibb Co LIM:BMY 57 Float Percentage Of Total Shares Outstanding is 99.97% as of Jul. 07, 2026. GuruFocus rates LIM:BMY with a GF Score™ of 57/100 and a GF Value™ of $55.40 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Bristol-Myers Squibb Co's float shares is 2,041.50 Mil. Bristol-Myers Squibb Co's total shares outstanding is 2,042.07 Mil. Bristol-Myers Squibb Co's float percentage of total shares outstanding is 99.97%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Bristol-Myers Squibb Co's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Bristol-Myers Squibb Co's Institutional Ownership is 55.64%.

LIM:BMY
57GF Score
Bristol-Myers Squibb Co LIM:BMY
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bristol-Myers Squibb Co Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Bristol-Myers Squibb Co's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=2,041.50/2,042.07
=99.97%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 99.97% mean?
Bristol-Myers Squibb Co (LIM:BMY) has a Float Percentage Of Total Shares Outstanding of 99.97% as of Jul. 07, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Bristol-Myers Squibb Co and its competitors.
Is Bristol-Myers Squibb Co's Float Percentage Of Total Shares Outstanding too high?
Bristol-Myers Squibb Co's current Float Percentage Of Total Shares Outstanding is 99.97%. Overall, Bristol-Myers Squibb Co has a GF Score™ of 57/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bristol-Myers Squibb Co's Float Percentage Of Total Shares Outstanding compare to PFE and GILD?
Bristol-Myers Squibb Co's Float Percentage Of Total Shares Outstanding of 99.97% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Drug Manufacturers company?
A good Float Percentage Of Total Shares Outstanding depends on the Drug Manufacturers industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Bristol-Myers Squibb Co and its competitors. Bristol-Myers Squibb Co's current Float Percentage Of Total Shares Outstanding is 99.97%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bristol-Myers Squibb Co stock overvalued right now?
Based on GuruFocus' analysis, Bristol-Myers Squibb Co (LIM:BMY) is currently considered Modestly Overvalued. The stock's GF Value™ is $55.40, compared to a current price of $56.98 — trading 2.9% above its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 99.97%. Bristol-Myers Squibb Co's overall GF Score™ is 57/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Bristol-Myers Squibb Co (LIM:BMY), the current Float Percentage Of Total Shares Outstanding is 99.97% as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bristol-Myers Squibb Co (LIM:BMY) Overvalued in 2026?

Based on GuruFocus' analysis, Bristol-Myers Squibb Co stock appears to be overvalued. The current stock price of $56.98 is trading 2.9% above its estimated GF Value™ of $55.40. GuruFocus considers Bristol-Myers Squibb Co to be Modestly Overvalued.

Key valuation signals for LIM:BMY:

  • Float Percentage Of Total Shares Outstanding: 99.97%
  • GF Value™: $55.40 vs. price of $56.98 (2.9% above fair value)
  • GF Score™: 57/100 with 5 warning signs

No single metric tells the full story. See the LIM:BMY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bristol-Myers Squibb Co Business Description

Address Route 206 and Province Line Road, Princeton, New Jersey, NJ, USA, 08543
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
57GF Score

Get the complete analysis for LIM:BMY

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$56.98
Price
$55.40
GF Value